CEACAM5 and malignant colon neoplasm: Carcinoembryonic antigen (CEA) has been widely used in colon cancer diagnosis, but more efficient molecular biomarkers for early diagnosis and advanced therapeutic agents are needed to improve prognosis and treatment outcomes in colon cancer patients [5].